Patents Assigned to KOSKA FAMILY LIMITED
  • Patent number: 11786661
    Abstract: The invention is a single use delivery device configured to enable reconstitution of a lyophilized agent (e.g., vaccine, drug, medicament, etc.) stored within for subsequent delivery of the reconstituted fluid agent to a patient in a controlled manner and without requiring specialized skill in reconstituting the agent or administering delivery of such agent. The delivery device is prefilled with an individual dose of a lyophilized agent and configured to be filled on-site and in the field with a dose of diluent for reconstitution of the lyophilized agent, while remaining sterile and preventing the potential for contamination during the filling process. The delivery device is further configured to be rendered incapable of reuse followings its intended use of delivering the fluid agent to a patient, thereby preventing reuse of the device and reducing the risk of the spreading blood-borne diseases through reuse.
    Type: Grant
    Filed: October 16, 2020
    Date of Patent: October 17, 2023
    Assignee: KOSKA FAMILY LIMITED
    Inventor: Marc Andrew Koska
  • Patent number: 11607369
    Abstract: A fluid delivery manifold system assembled and configured to allow delivery of a single dose of a therapeutic agent (e.g., vaccine, drug, medicament, etc.) from a Blow-Fill-Seal (BFS) vial to a patient. The delivery assembly generally includes a modular manifold design consisting of separately constructed components cooperatively arranged and coupled to one another. The modular manifold construction allows for rapid manufacturing reconfigurations of one or more components with minimal costs to create new delivery manifold configurations that meet specific needs (i.e., different modes of delivery depending on agent to be delivered, such as subcutaneous, intramuscular, intradermal, intravenous injection, spray, or droplet delivery).
    Type: Grant
    Filed: May 18, 2020
    Date of Patent: March 21, 2023
    Assignee: KOSKA FAMILY LIMITED
    Inventors: Marc Andrew Koska, Jay S. Walker
  • Patent number: 11382833
    Abstract: The invention provides for a delivery system including a delivery assembly configured to allow delivery of a single dose of a therapeutic agent (e.g., vaccine, drug, medicament, etc.) from a Blow-Fill-Seal (BFS) vial to a patient. The delivery assembly generally includes a modular design consisting of separately constructed components cooperatively arranged and coupled to one another. The modular construction allows for rapid manufacturing reconfigurations of one or more components with minimal costs to create new delivery assembly configurations that meet specific needs (i.e., different modes of delivery depending on agent to be delivered, such as subcutaneous, intramuscular, intradermal, intravenous injection, spray, or droplet delivery). The delivery assembly is generally configured to be filled on-site and in the field and is further capable of delivery of the agent in a controlled manner and without requiring specialized skill in administering delivery of such agent.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: July 12, 2022
    Assignee: KOSKA FAMILY LIMITED
    Inventor: Marc Andrew Koska
  • Patent number: 10835678
    Abstract: The invention is a single use delivery device configured to enable reconstitution of a lyophilized agent (e.g., vaccine, drug, medicament, etc.) stored within for subsequent delivery of the reconstituted fluid agent to a patient in a controlled manner and without requiring specialized skill in reconstituting the agent or administering delivery of such agent. The delivery device is prefilled with an individual dose of a lyophilized agent and configured to be filled on-site and in the field with a dose of diluent for reconstitution of the lyophilized agent, while remaining sterile and preventing the potential for contamination during the filling process. The delivery device is further configured to be rendered incapable of reuse followings its intended use of delivering the fluid agent to a patient, thereby preventing reuse of the device and reducing the risk of the spreading blood-borne diseases through reuse.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: November 17, 2020
    Assignee: KOSKA FAMILY LIMITED
    Inventor: Marc Andrew Koska
  • Patent number: D992110
    Type: Grant
    Filed: August 10, 2021
    Date of Patent: July 11, 2023
    Assignee: KOSKA FAMILY LIMITED
    Inventors: Jeff Price, Marc Andrew Koska